Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 10 Aug, 01:00 am
RBC Capital's Positive Outlook: RBC Capital increased its price target for RioCan (OTC: RIOCF) to C$25.00 and maintained an "Outperform" rating, signaling confidence in the REIT's stock outlook . Robust Operational Performance: RioCan achieved an impressive 98.80% retail committe
Vistra Corp (NYSE: VST) Navigates Q3 Earnings Miss with Strong Core Operations Vistra Corp (NYSE: VST) reported a Q3 earnings miss, with earnings per share of $1.68 against an expected $2.43, and revenue of $5.00 billion falling short of $5.46 billion. The primary factor for the
Berkshire Hathaway's upcoming Q2 earnings report on August 8, 2026, is highly anticipated, with analysts forecasting earnings of $5.04 per share and revenue of $96.52 billion . The company's significant stock buybacks , potentially up to $11 billion , signal strong management con
Analyst Outlook: Cogent Communications Holdings, Inc. (NASDAQ: CCOI) received a lowered price target from Goldman Sachs, though analysts still project a 25.26% upside. Market Performance: The telecom stock has experienced a significant decline, hitting a new 52-week low and refle
Analyst Confidence: Scotiabank increased its price target for BCE Inc. (NYSE: BCE) to C$40 , maintaining an "Outperform" rating, signaling strong market confidence in the telecommunications stock . Strong Q2 Performance: The telecom giant reported robust Q2 2026 results, with adj
PPL Corporation (NYSE:PPL) Q2 2026 Earnings: Navigating Missed Estimates and Reaffirmed Outlook Earnings Miss : PPL's second-quarter 2026 earnings per share (EPS) of $0.33 fell short of analyst consensus estimates. Revenue Performance : The company's quarterly revenue of $2.11 bi
Cantor Fitzgerald raised its price target for MercadoLibre (NASDAQ: MELI) to $2,300 , indicating a 25.86% potential upside for the Latin American e-commerce giant . The company reported a 50% year-over-year revenue increase, reaching $10.2 billion , and a GAAP earnings per share
Goldman Sachs has lowered its price target for Fiserv to $54.00 from $60.00 , maintaining a "Neutral" rating. Fiserv revised its 2026 full-year organic revenue outlook to a range of 1% decline to flat, a significant reduction from previous forecasts. The company also decreased it
Take-Two Interactive Software, Inc. reported an EPS of $0.36 , surpassing analyst estimates of $0.33 . The company achieved strong sales with revenue of $1.53 billion and net bookings of $1.39 billion , both exceeding expectations. Despite a year-over-year decline in profitabilit
Wall Street analysts project strong Q2 2026 earnings for Berkshire Hathaway, with an estimated EPS of $7,553.16 and revenue of $96.52 billion . A significant $11 billion stock buyback signals management's confidence in Berkshire Hathaway's valuation and could boost future earning
Accelerated FDA Approval: Replimune's melanoma drug, Tudriqev, received accelerated approval from the U.S. Food and Drug Administration (FDA) on its third attempt, based on a 24.20% objective response rate. Analyst Price Target Increase: BMO Capital raised its price target for RE
Microchip Technology (NASDAQ: MCHP) reported robust Q1 2027 financial results , with net sales reaching $1.485 billion , a 38% year-over-year increase. Analyst firm B. Riley reiterated a "Buy" rating for Microchip Technology, setting a new price target of $108 , suggesting signif
Global Partners LP (NYSE:GLP) reported a strong Q2 earnings per share (EPS) of $1.86 , significantly surpassing analyst estimates. Despite the EPS beat, Global Partners LP 's Q2 revenue of $6.79 billion fell short of expectations, potentially due to market pressures. The energy p
Microvast Holdings, Inc. (NASDAQ: MVST) Set to Announce Q2 2026 Financial Results Microvast Holdings, Inc. (NASDAQ: MVST) will release its Q2 2026 financial results on Monday, August 10, 2026, after market close. Analysts project a consensus earnings per share (EPS) of -$0.01 and
Wells Fargo raised the price target for Unity to $48.00 , indicating a potential 17.62% upside for investors. Unity Software Inc. reported strong Q2 revenue of $546.47 million , significantly surpassing analyst expectations . The company achieved a surprise adjusted EPS of $0.28
FDA Approval: Replimune Group Inc. (NASDAQ: REPL) secured FDA approval for Tudriqev, its first drug, targeting a challenging form of skin cancer. Positive Market Reaction: Replimune's stock experienced a significant daily increase, reflecting strong investor confidence. Analyst C
China Yuchai International (NYSE: CYD) Reports First-Half Earnings Miss Despite Strong Revenue Growth and “Strong Buy” Rating Earnings Miss: China Yuchai International (NYSE: CYD) reported diluted earnings per share of approximately $2.17 , below the analyst estimate
Barclays increased its price target for Kraft Heinz , signaling a more positive investment outlook. Kraft Heinz surpassed Q2 earnings and revenue estimates, driven by strong financial performance. Despite a slight decline in organic net sales, the company's improved sales guidanc
Headlines provided by Investing.com